Clinical Trial Update: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 feasibility trial evaluating the combination of tazemetostat with CAR T-cell therapy in B-cell lymphomas, including follicular lymphoma, mantle cell lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• CAR-T cell therapy
• Tazemetostat (tazemetostat)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Follicular Lymphoma, B-Cell Lymphoma | Phase 1 | Status: RECRUITING